
Evommune Inc (EVMN) Earnings Dates & Reports
Evommune Inc (EVMN) Most Recent Earnings
Report Date
Period EndingQ4 2025
Est. EPS-$0.75
Actual EPS-$1.43
EarningsMiss
Evommune Inc (EVMN) Earnings
View the latest Evommune Inc (EVMN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Evommune Inc (EVMN)
Order type
Buy in
Order amount
Est. shares
0 shares
Evommune Inc (EVMN) Earnings per Share (EPS) History
Signup for full accessBrowse free
Evommune Inc (EVMN) Latest Earnings
The value each EVMN share was expected to gain vs. the value each share gained.
Evommune Inc (EVMN) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$1.43. This exceeded analysts' expectations of -$0.75 by 90.67%, marking a Miss.
For comparison, Evommune Inc reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.69.
Evommune Inc (EVMN) Earnings History
Evommune Inc (EVMN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Evommune Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — |
Evommune Inc (EVMN) Earnings FAQs
Evommune Inc (EVMN) last reported earnings on Mar 5, 2026 for Q4 2025, posting an EPS of -$1.43, which Miss the estimate of -$0.75 by 90.67%.
For Q4 2025, Evommune Inc (EVMN) reported an EPS of -$1.43, missing analysts' estimate of -$0.75 by 90.67%.
For Q4 2025, Evommune Inc (EVMN) Miss expectations with an actual EPS of -$1.43 vs. an estimated EPS of -$0.75.
Following the last earnings report on Mar 5, 2026, Evommune Inc (EVMN)'s stock price moved — from — to —.
The next Evommune Inc (EVMN) earnings call is scheduled for May. 7, 2026, where executives will discuss financial results and outlook.